EUGENE A. HALL - 06 Nov 2023 Form 4 Insider Report for GARTNER INC (IT)

Signature
/s/ Kevin Tang for Eugene A. Hall
Issuer symbol
IT
Transactions as of
06 Nov 2023
Net transactions value
-$23,098,371
Form type
4
Filing time
08 Nov 2023, 16:39:53 UTC
Previous filing
05 Sep 2023
Next filing
04 Dec 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IT Common Stock Options Exercise $13,184,378 +92,192 +8% $143.01 1,237,911 06 Nov 2023 Direct F1
transaction IT Common Stock Disposed to Issuer $13,184,463 -33,585 -2.7% $392.57 1,204,326 06 Nov 2023 Direct F2
transaction IT Common Stock Tax liability $9,053,057 -23,061 -1.9% $392.57 1,181,265 06 Nov 2023 Direct F3
transaction IT Common Stock Sale $5,248,593 -13,248 -1.1% $396.18 1,168,017 07 Nov 2023 Direct F4
transaction IT Common Stock Sale $3,636,034 -9,197 -0.79% $395.35 1,158,820 07 Nov 2023 Direct F5
transaction IT Common Stock Sale $3,208,813 -8,138 -0.7% $394.30 1,150,682 07 Nov 2023 Direct F6
transaction IT Common Stock Sale $1,788,033 -4,546 -0.4% $393.32 1,146,136 07 Nov 2023 Direct F7
transaction IT Common Stock Sale $163,756 -417 -0.04% $392.70 1,145,719 07 Nov 2023 Direct F8

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IT Stock Appreciation Rights Options Exercise $0 -92,192 -100% $0.000000* 0 06 Nov 2023 Common Stock 92,192 $143.01 Direct F9
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares acquired upon exercise of SARs.
F2 Represents shares withheld that had an aggregate value, based on the market price on the date of exercise, substantially equal to the aggregate exercise price of the SARs.
F3 Represents shares withheld for the payment of applicable income and payroll withholding taxes.
F4 This transaction was executed in multiple trades at prices ranging from $395.74 to $396.73. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F5 This transaction was executed in multiple trades at prices ranging from $394.77 to $395.74. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F6 This transaction was executed in multiple trades at prices ranging from $393.77 to $394.75. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F7 This transaction was executed in multiple trades at prices ranging from $392.77 to $393.75. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F8 This transaction was executed in multiple trades at prices ranging from $392.64 to $392.75. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F9 These SARs are part of an award that became exercisable in four substantially equal annual installments, commencing on February 6, 2020, and are fully exercisable.